8-K filing — ALX ONCOLOGY HOLDINGS INC (ALXO)
Filed: 2026-08-06 AccNo: 0001193125-26-336843 Size: 431 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
ALX Oncology Holdings Q2 Adj. EPS $(0.11) Beats $(0.14) Estimate
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 75 percent increase over losses of $(0.44) per share
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 12:39 PM
- Checked
- Aug 6, 2026, 12:40 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading